To:
(Enter e-mail address of recipient)
From:
(Enter your e-mail address)
Subject:
Comments:
(Customise the e-mail with your own comments)
  Novogen Anti-Cancer Drug Enters Phase I Trials
Australian pharmaceutical company, Novogen Limited, today announced that its anti-cancer drug, NV-06, has been approved ...